Quantitative determinations of duodenogastric reflux, prevalence of Helicobacter pylori infection, and concentrations of interleukin-8

World Journal of Surgery

Volumn 27, Issue 5, 2003, Pages 567-570

  Fukuhara, Kenichiro ^a   Osugi, Harushi ^a   Takada, Nobuyasu ^a   Takemura, Masashi ^a   Ohmoto, Yasukazu ^b   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ADULT; AGED; ARTICLE; DUODENOGASTRIC REFLUX; FEMALE; GASTRECTOMY; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; ROUX Y ANASTOMOSIS; STOMACH CANCER; STOMACH MUCOSA;

ADULT; AGED; AGED, 80 AND OVER; DUODENOGASTRIC REFLUX; FEMALE; GASTRECTOMY; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0043076036     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-6796-z     Document Type: Article

References (18)

1. Yoshino K. History of gastric cancer surgery. J. Jpn. Surg. Soc. 2000; 101:855
2. Kim BJ, O'Connell T. Gastroduodenostomy after gastric resection for cancer. Am. Surg. 1999;65:905
3. Kawakita N, Nagahata Y, Azumi Y, et al. Residual gastritis after gastrectomy and Helicobacter pylori - its clinical significance. Jpn. J. Gastroenterol. 1995;92:862
4. Marshall REK, Anggiansah A, Owen WA, et al. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997;40:182
5. Belair PA, Metz DC, Faigel DO, et al. Receiver operator characteristic analysis of endoscopy as a test for gastritis. Dig. Dis. Sci. 1997;42:2227
6. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis - the updated Sydney System. Am. J. Pathol. 1996;20:1161
7. Sato Y, Sugimura K, Mochizuki T, et al. Regional differences on production of chemokines in gastric mucosa between Helicobacter pyloripositive duodenal ulcer and gastric ulcer. Dig. Dis. Sci. 1999; 44:2390
8. Aihara M, Azuma A, Takizawa H, et al. Molecular analysis of suppression of IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig. Dis. Sci. 1998;43:174
9. Fukuhara K, Osugi H, Takada N, et al. A study to determine which reconstructive procedure after distal gastrectomy for gastric cancer is best in preventing duodenogastroesophageal reflux. World J. Surg. 2002;26:1452
10. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd English ed. Gastric Cancer 1998;1:10
11. Ochiai A, Hirohashi S. Genetic alterations in the precursors of gastric cancer. In Tahara E., editor, Molecular pathology of gastroenterological cancer: application to clinical practice, Tokyo, Springer-Verlag, 1997;43-53
12. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994;305:253
13. Mason RJ, DeMeester TR. Importance of duodenogastric reflux in the surgical outpatient practice, Hepatogastroenterology 1999;46:48
14. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide 1/interleukin 8, a novel cytoline that activates neutrophils. J. Clin. Invest. 1989;84:1045
15. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615
16. Warren JR, Marshall B. Unidentified bacilli on gastric epithelium in active chronic gastritis, Lancet 1983;1:1273
17. Gionchetti P, Vaira D, Campieri M, et al. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am. J. Gastroenterol. 1994;89:883
18. Georgopoulos SD, Ladas SD, Karatapanis S, et al. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromicin. Dig. Dis. Sci. 2000;45:63